Loading…
Disclosed for 92 months, Jan 2019 to Sep 2026.
quant Focused Fund is an active equity fund in the Focused category from quant Mutual Fund. In April 2020 it disclosed 14 stocks worth ₹4.1 Cr, up ₹74 L from Mar 2020. Its largest positions were HDFC Bank Limited (10.2%), Bharti Airtel Limited (9.5%), Biocon Limited (9.3%); the ten largest together made up 73.6% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 33.2% of its equity. Cash and debt stood at 17.3%. Compared with Mar 2020 the fund entered 7 new stocks and exited 12.
Top-10 weight is higher than 100% of peers
Holds more stocks than 0% of peers
Holds more cash than 100% of peers
What these mean: concentration · cash
Every line the fund disclosed, with the change against Mar 2020. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Cash, TREPS & receivables | 17.25% | up 6.25 pts | ₹71 L | up ₹34 L | Added |
| HDFC Bank Limited | 10.18% | up 10.18 pts | ₹42 L | up ₹42 L | New |
| Bharti Airtel Limited | 9.55% | up 0.63 pts | ₹39 L | up ₹9 L | Added |
| Biocon Limited | 9.27% | up 9.27 pts | ₹38 L | up ₹38 L | New |
| SBI Life Insurance Company Limited | 9.08% | up 9.08 pts | ₹37 L | up ₹37 L | New |
| Alembic Pharmaceuticals Limited | 8.53% | up 4.98 pts | ₹35 L | up ₹23 L | Added |
| Godrej Consumer Products Limited | 6.97% | up 0.60 pts | ₹29 L | up ₹7 L | Added |
| Petronet LNG Limited | 6.26% | up 2.95 pts | ₹26 L | up ₹15 L | Added |
| Torrent Pharmaceuticals Limited | 5.46% | up 5.46 pts | ₹23 L | up ₹23 L | New |
| Nippon Life India Asset Management Limited | 5.39% | down 1.23 pts | ₹22 L | down ₹0 L | Trimmed |
| HDFC Life Insurance Company Limited | 2.94% | up 2.94 pts | ₹12 L | up ₹12 L | New |
| ICICI Lombard General Insurance Company Limited | 2.93% | up 2.93 pts | ₹12 L | up ₹12 L | New |
| GlaxoSmithKline Pharmaceuticals Limited | 2.87% | down 0.17 pts | ₹12 L | up ₹2 L | Added |
| ITC Limited | 1.96% | up 0.13 pts | ₹8 L | up ₹2 L | Added |
| Divi's Laboratories Limited | 1.37% | up 1.37 pts | ₹6 L | up ₹6 L | New |
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Compared with
Since Mar 2020, the weight rose most in Insurance (+18.1 pts) and Pharmaceuticals & Biotechnology (+9.6 pts), and fell most in IT - Software (−10.8 pts) and Beverages (−6.6 pts).
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
| Sector | Apr 2019 | Oct 2019 | Dec 2019 | Mar 2020 | Apr 2020 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 11.0% | 4.2% | 6.7% | 23.6% | 33.2% |
| Insurance | 10.1% | 24.2% | 21.7% | — | 18.1% |
| Banks | 11.9% | 16.8% | 23.2% | 6.0% | 12.3% |
| Telecom - Services | — | 3.2% | — | 10.0% | 11.5% |
| Personal Products | — | — | — | 10.9% | 8.4% |
| Gas | — | 3.1% | 3.2% | 3.7% | 7.6% |
| Capital Markets | — | 10.1% | 6.9% | 7.4% | 6.5% |
| Diversified FMCG | 4.7% | — | — | 8.8% | 2.4% |
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
| ₹846 Cr |
| 13 |
| 7 |
| 5 |
| −4.0% |
| 3.3% |
| 6% |
| May 2026 | ₹840 Cr | 11 | 3 | 2 | −6.1% | 0.5% | 6% |
| Apr 2026 | ₹813 Cr | 10 | 2 | 2 | −5.6% | 0.8% | 6% |
| Mar 2026 | ₹703 Cr | 10 | 1 | 3 | −5.2% | 2.2% | 6% |
| Feb 2026 | ₹827 Cr | 12 | 4 | 2 | 5.3% | 12.1% | 6% |
| Jan 2026 | ₹848 Cr | 10 | 0 | 5 | −3.9% | 0.5% | 6% |
| Dec 2025 | ₹914 Cr | 15 | 5 | 2 | −4.7% | 0.5% | 5% |
| Nov 2025 | ₹944 Cr | 12 | 4 | 4 | 3.1% | 8.7% | 477% |
| Oct 2025 | ₹975 Cr | 12 | 1 | 2 | 2.0% | 8.6% | 418% |
| Sep 2025 | ₹975 Cr | 13 | 1 | 3 | −<0.1% | 4.4% | 363% |
| Aug 2025 | ₹977 Cr | 15 | 1 | 2 | −4.5% | 1.4% | 391% |
| Jul 2025 | ₹1,017 Cr | 16 | 6 | 6 | −1.2% | 5.0% | 407% |
| Jun 2025 | ₹1,074 Cr | 16 | 2 | 1 | −5.8% | 0.5% | 418% |
| May 2025 | ₹1,050 Cr | 15 | 4 | 4 | −3.1% | 3.9% | 440% |
| Apr 2025 | ₹1,021 Cr | 15 | 1 | 5 | −4.5% | 1.0% | 438% |
| Mar 2025 | ₹1,013 Cr | 19 | 6 | 4 | −4.2% | 0.7% | 445% |
| Feb 2025 | ₹966 Cr | 17 | 6 | 6 | 1.1% | 2.1% | 425% |
| Jan 2025 | ₹1,064 Cr | 17 | 1 | 2 | 0.3% | 1.7% | 422% |
| Dec 2024 | ₹1,075 Cr | 18 | 1 | 0 | 0.5% | 1.5% | 426% |
| Nov 2024 | ₹1,118 Cr | 17 | 2 | 0 | −0.2% | 0.7% | 453% |
| Oct 2024 | ₹1,121 Cr | 15 | 2 | 1 | 6.1% | 6.1% | 497% |
For any of the 68 earlier months, choose it in “Portfolio as of” at the top of the page.